Please login to the form below

Not currently logged in
Email:
Password:

Roche buys mtm laboratories

Roche has completed the full acquisition of Germany-based mtm laboratories, a company specialising in products for cervical cancer diagnosis

Roche has completed the full acquisition of Germany-based mtm laboratories, a company specialising in products for cervical cancer diagnosis.

Roche will pay €130m upfront, with a further €60m available to mtm shareholders depending on performance-related milestones.

The transaction is expected to close in the coming weeks, with mtm to become part of Roche's tissue diagnostics unit, Ventana Medical Systems.

Commenting on the deal, Daniel O'Day, chief operating officer, Roche Diagnostics, said mtm's products are "highly complementary" to Roche's current 'cobas' diagnostic technologies for human papiloma virus (HPV) – a common cause of cervical cancer.

As part of the deal, Roche will acquire mtm's tools for diagnosis, including a test to measure levels of the p16 biomarker, with a significant increase associated with persistent HPV infection and the possibility of cancer development.

"The combination of cobas HPV and p16 tests may redefine the standard of care for cervical cancer testing by improving detection, reducing unnecessary cervical biopsies, and improving the confirmation of cervical pre-cancer," said O'Day.

19th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics